BiotechTube
Home/Valitor/Wesley Jackson, PhD
WJ

Wesley Jackson, PhD

President, Chief Scientific Officer & Member of the Board

Valitor

Therapeutic Areas

Ophthalmology

Valitor Pipeline

DrugIndicationPhase
VLTR-559Wet Age-Related Macular Degeneration (wet AMD)Pre-clinical

Leadership Team at Valitor

GD
Gregory D. Kunst
Chief Executive Officer
WS
William S. (Sandy) White, PharmD, MBA
Executive Development Advisor
OJ
Omkar Joshi, PhD
Chief Technical Officer
View full Valitor profile